The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

MPN Advances Day 2019 | Objectively measuring responses in MPNs

Name: Objectively measuring responses in MPNs
Uploaded: 2019-11-15T00:00:00.000Z
Duration: 1 min 26 s
Description: Nauman Butt, MB BCh, MRCP, MD, FRCPath, Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool, UK, outlines the everyday clinical challenges for the management of myeloproliferative neoplasms (MPNs), with a focus on objectively measuring patient response. This interview took place at the Myeloproliferative Neoplasms Conference 2019 in London, UK.

Nauman Butt • 15 Nov 2019

MPN Advances Day 2019

Myeloproliferative Neoplasms

Nauman Butt, MB BCh, MRCP, MD, FRCPath, Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool, UK, outlines the everyday clinical challenges for the management of myeloproliferative neoplasms (MPNs), with a focus on objectively measuring patient response. This interview took place at the Myeloproliferative Neoplasms Conference 2019 in London, UK.